Published in Gene Therapy Weekly, May 15th, 2003
The method was developed in collaboration with Dr. Louis Deiss of the University of Illinois at Chicago. Quark Biotech holds the patent to this method, and to one of its variants that forms the basis of BiFAR, Quark's core technology platform.
The findings from this study and a description of the innovative methodology were published in the March 2003 issue of Oncogene.
"This study describes a method to directly uncover genes and proteins...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly